Skip to main content
Premium Trial:

Request an Annual Quote

Cynvenio Launches Early Access Program for Liquid Biopsy Platform

NEW YORK (GenomeWeb) – Cynvenio Biosystems today announced the launch of an early access program for its LiquidBiopsy Rare Cell Isolation Platform.

The Mayo Clinic Cancer Center and the Norris Comprehensive Cancer Center, part of the Keck School of Medicine at the University of Southern California, are the first centers to participate in the program, which allows cancer research laboratories to have direct, on-site access to genomic material from highly purified cell populations for analysis. The LiquidBiopsy platform automates the identification and enrichment of rare tumor cells from standard patient blood draws, and delivers ultra-high sample purity for next-generation sequencing, PCR, expression analysis, fluorescent in situ hybridization, and immunohistochemistry.

The platform, Cynvenio added, can detect as few as one target cell per milliliter. Its technology has been available as a CLIA lab service to doctors and pharmaceutical firms since 2013, Cynvenio CEO André de Fusco said. "Our goal for the new LiquidBiopsy platform program is to enable those at the forefront of cancer research to unlock the complexities of tumor heterogeneity, concordance between sample types, and longitudinal patient monitoring," he said in a statement.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.